Close

Analyst Ratings for BioSante Pharmaceuticals (BPAX)

BPAX Rating Summary

  |   Expand Research on BPAX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 1.7 / 10
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/15/2011 Roth Capital N/A Downgrade Neutral
(N/A)		 N/A
(N/A)		 2.12
(0.45)		 -78.77% Details
12/15/2011 Rodman & Renshaw N/A Downgrade Market Perform
(N/A)		 N/A
(N/A)		 2.12
(0.45)		 -78.77% Details